A University of Colorado Cancer Center study published today in the journal Cancer shows that using crizotinib to treat ALK positive non-small cell lung cancer (NSCLC) appears to reduce kidney function when assessed by one of the most commonly used clinical methods.
Moyed Miften, PhD, and CU Cancer Center colleagues show that mis-positioning of endorectal balloon during prostate cancer radiation may affect treatment success.
Largest Ever Study of Male Breast Cancer Treatment Shows More Mastectomy, Less Radiation Than in Female Disease
October 31, 2013 · Comments Off
University of Colorado Cancer Center researchers used data from 4,276 cases of male breast cancer and 718,587 cases of female breast cancer to show that the disease is treated differently in men than in women. Specifically, male breast cancer is treated with mastectomy more often than female breast cancer, and in cases in which locally advanced female breast cancer is commonly treated with radiation, the treatment is less used in the male disease.
$5.9M Grant Adds Androgen Receptor as a New Driver and Target in Breast Cancer
October 1, 2013 · Comments Off
A major Department of Defense grant to researchers Jennifer Richer, PhD, and Anthony Elias, MD, at the University of Colorado Cancer Center aids development of drugs that target androgen receptors as a driver of breast cancer.
CU Cancer Center Study: Young patients with metastatic colorectal cancer at higher risk
September 30, 2013 · Comments Off
AURORA, Colo. – Younger patients with colorectal cancer that has spread to other parts of...
Study: Redefining the criteria for ALK positive lung cancer
September 10, 2013 · Comments Off
A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug.
Review of online tools to predict cancer prognosis
September 3, 2013 · Comments Off
A recent review from researchers at the Kaiser Permanente Colorado Institute for Health Research and the University of Colorado Cancer Center details the range of online tools that providers and patients can use to inform cancer prognosis.
“Jolie Effect” may cause increase in women getting genetic testing.
August 27, 2013 · Comments Off
There may be an increase in women turning towards genetic testing for breast cancer risk...
Wait times up 78 percent at VA for colorectal cancer procedures
August 26, 2013 · Comments Off
A study published in the August print issue of the Journal of Oncology Practice shows that from 1998-2008, wait times for colorectal cancer operations at Veterans Administration hospitals increased from 19 to 32 days. But researchers think longer waits may be a reflection of several unmeasured variables including more careful care, staffing, and patient conditions or preferences.
NTRK1: a new oncogene and target in lung cancer
August 26, 2013
The Men’s Event celebrates 40 years at Elway’s, raises $120k
December 10, 2013 · No comments
American Gastroenterological Association – Funding Opportunity
December 9, 2013 · No comments
alk drug lung cancer amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis microRNA Monique Spillman Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith